It is well known that coenzyme Q (CoQ) serves as an essential carrier for electron transport and proton translocation in the mitochondrial respiratory chain (1, 2) . CoQ in the body of human beings is thought to be provided by not only biosynthesis de novo (3) but also by dietary intake of CoQ. However, it is not clear how much dietary intake of coenzyme Q10 (CoQ10) contributes to the body level of CoQ10 nor what kind of effect it has on metabolism of endogenous CoQ10.
At present, total parenteral nutrition (TPN) is widely used as a life-saving treatment for many severely ill patients who cannot orally take in adequate quantities of nutrients (4). However, patients receiving TPN (TPN patients) cannot ingest exogenous CoQ10 unless fat emulsions, which usually contain egg yolk lecithin and soybean oil, are given. The levels of CoQ10 in such TPN patients, therefore, are expected to indicate an endogenous supply of CoQ10 in man.
In this paper, we describe serum levels of CoQ10 in TPN patients and the relationships to other serum lipids, and discuss clinical and nutritional aspects of exogenous CoQ10. TPN patients were also divided into two groups of patients with hepatic and/or small intestinal diseases (3), 6), 9), 10) and 11) in group A and 2), 3), 4), 7),10),11) and 12) in group C in Table 1 ) and of patients with other diseases, because the impairment of the digestive system might cause a disturbance of hepatic intestinal circulation of CoQ10 which would result in a reduction in the serum level of CoQ10. However, there was no significant difference between the CoQ10 levels of these two groups. 
Serum levels of lipids
The serum levels of lipids in patients receiving TPN for more than 1week are summarized in Table 4 . Among the 10 items determined , the mean serum levels of T-Chol and E-Chol in the patients respectively declined by approximately 21% and 19% in comparison with the lowest values of their normal ranges . Other lipid levels, however, were all within the respective normal ranges. Table 4 also shows correlation coefficients between serum CoQ10 and other lipid levels in TPN patients . The serum levels of HDL-Chol, TG, PL, LDL, and CM as well as T-Chol correlated significantly with CoQ10 levels. The correlation coefficients of these lipids to CoQ10 were mostly smaller than 0.6. The relationships between CoQ10 levels and T-Chol , TG or PL levels in TPN patients are also depicted in Fig . 1 . The regression curves drawn from these plotted points suggest that CoQ10 decreases at a much faster rate than other serum lipids during TPN. Serum levels of T-Chol in 29 patients before and after TPN are shown in Table  5 . T-Chol levels of the patients declined only to about 87% of those before TPN after one week of TPN therapy, and then were maintained almost constant . However, no statistical difference was observed between the levels before and after TPN .
DISCUSSION
In the present study, the serum levels of CoQ10 in the patients were already significantly lower, even before receiving TPN , than those in normal subjects, and they declined further during TPN to less than 50% of those in the normal subjects . It may be simply supposed that the difference between the levels before and after receiving TPN indicate endogenous and exogenous CoQ10 supplies . However, the low levels of CoQ10 in patients before TPN may be attributed to fatal disease , medication, or insufficient food intake. Various papers have indicated that many factors may affect tissue levels and the biosynthetic capability of CoQ10 . For example, several investigators have claimed that low levels of CoQ10 are observed in patients with muscular dystrophy (13), essential hypertension (14) Chol supplementation, however, serum levels of CoQ10 decreased more drastically and rapidly than those of T-Chol. Therefore, endogenous CoQ10 supply in TPN patients appears to be insufficient as compared to Chol. Many papers have recently pointed out the clinical importance of CoQ10 (33) . Saiki et al. (34) reported that CoQ stimulated the host defense mechanisms involving macrophage-mediated functions such as cytolysis, cytostasis and H2O2 release against neoplastic cells and microorganisms. Crawford and Schneider (35) reported that CoQ10 was identified as a component of the microbicidal oxidase system in neutrophils. Patients with cancer are usually immunosuppressive , the latter being severe especially in chemotherapy. From the above, we consider that CoQ10 supplementation to TPN patients may be desirable for the improvement of their serious physical condition. 
